ArticleThe journal of gene medicine2010

Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution.

Xiong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.